Jen-Chywan Wang

Dr. Jen-Chywan Wang


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015
Verified
Book Chapter
Closed access
PDF file
TKTaiyi Kuo
Taiyi Kuo
AMAllison McQueen
Allison McQueen
TCTzu-Chieh Chen
Tzu-Chieh Chen
JWJen-Chywan Wang
Jen-Chywan Wang

22 October 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JWJen-Chywan Wang
Jen-Chywan Wang
MDMika Kakefuda Derynck
Mika Kakefuda Derynck
DNDaisuke F. Nonaka
Daisuke F. Nonaka
DKDaniel B. Khodabakhsh
Daniel B. Khodabakhsh
CHChris Haqq
Chris Haqq
KYKeith R. Yamamoto
Keith R. Yamamoto
The global physiological effects of glucocorticoids are well established, and the framework of transcriptional regulation by the glucocorticoid receptor (GR) has been described. However, the genes directly under GR control that trigger these physiological effects are largely unknown. To address this issue in a single cell type, we identified glucocorticoid-responsive genes in A549 human lung adenocarcinoma cells by microarray analysis and quantitative real-time PCR. Reduction of GR expression by RNA interference diminished the effects of dexamethasone on all tested target genes, thus confirming the essential role of GR in glucocorticoid-regulated gene expression. To identify primary GR target genes, in which GR is a component of the transciptional regulatory complex, we developed a strategy that uses chromatin immunoprecipitation to scan putative regulatory regions of target genes for sites occupied by specifically bound GR. We screened 11 glucocorticoid-regulated genes, and we identified GR-binding regions for eight of them (five induced and three repressed). Thus, our approach provides a means for rapid identification of primary GR target genes and glucocorticoid-response elements, which will facilitate analyses of transcriptional regulatory mechanisms and determination of hormone-regulated gene networks.

1 November 2013 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
TKTaiyi Kuo
Taiyi Kuo
CHCharles A. Harris
Charles A. Harris
JWJen-Chywan Wang
Jen-Chywan Wang

14 November 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
IRInez Rogatsky
Inez Rogatsky
JWJen-Chywan Wang
Jen-Chywan Wang
MDMika K. Derynck
Mika K. Derynck
DNDaisuke F. Nonaka
Daisuke F. Nonaka
DKDaniel B. Khodabakhsh
Daniel B. Khodabakhsh
KYKeith R. Yamamoto
Keith R. Yamamoto
The glucocorticoid receptor (GR) activates or represses transcription depending on the sequence and architecture of the glucocorticoid response elements in target genes and the availability and activity of interacting cofactors. Numerous GR cofactors have been identified, but they alone are insufficient to dictate the specificity of GR action. Furthermore, the role of different functional surfaces on the receptor itself in regulating its targets is unclear, due in part to the paucity of known target genes. Using DNA microarrays and real-time quantitative PCR, we identified genes transcriptionally activated by GR, in a translation-independent manner, in two human cell lines. We then assessed in U2OS osteosarcoma cells the consequences of individually disrupting three GR domains, the N-terminal activation function (AF) 1, the C-terminal AF2, or the dimer interface, on activation of these genes. We found that GR targets differed in their requirements for AF1 or AF2, and that the dimer interface was dispensable for activation of some genes in each class. Thus, in a single cell type, different GR surfaces were used in a gene-specific manner. These findings have strong implications for the nature of gene response element signaling, the composition and structure of regulatory complexes, and the mechanisms of context-specific transcriptional regulation.

1 March 1995 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
RORichard M. O'BRien
Richard M. O'BRien
ENEdouard L. Noisin
Edouard L. Noisin
ASAdisak Suwanichkul
Adisak Suwanichkul
TYTomoyuki Yamasaki
Tomoyuki Yamasaki
PLPeter C. Lucas
Peter C. Lucas
DGDaryl K. Granner
Daryl K. Granner
The rate of transcription of the hepatic phosphoenolpyruvate carboxykinase (PEPCK) and insulin-like growth factor-binding protein 1 (IGFBP-1) genes is stimulated by glucocorticoids and inhibited by insulin. In both cases, the effect of insulin is dominant, since it suppresses both basal and glucocorticoid-stimulated PEPCK or IGFBP-1 gene transcription. Analyses of both promoters by transfection of PEPCK or IGFBP-1-chloramphenicol acetyltransferase fusion genes into rat hepatoma cells has led to the identification of insulin response sequences (IRSs) in both genes. The core IRS, T(G/A)TTTTG, is the same in both genes, but the PEPCK promoter has a single copy of this element whereas the IGFBP-1 promoter has two copies arranged as an inverted palindrome. The IGFBP-1 IRS and PEPCK IRS both bind the alpha and beta forms of hepatic nuclear factor 3 (HNF-3), although the latter does so with a sixfold-lower relative affinity. Both the PEPCK and the IGFBP-1 IRSs also function as accessory factor binding sites required for the full induction of gene transcription by glucocorticoids. A combination of transient transfection and DNA binding studies suggests that HNF-3 is the accessory factor that supports glucocorticoid-induced gene transcription. In both genes, the HNF-3 binding site overlaps the IRS core motif(s). A model in which insulin is postulated to mediate its negative effect on glucocorticoid-induced PEPCK and IGFBP-1 gene transcription indirectly by inhibiting HNF-3 action is proposed.

20 December 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CYChi-Yi Yu
Chi-Yi Yu
OMOleg Mayba
Oleg Mayba
JLJoyce V Lee
Joyce V Lee
JTJoanna Tran
Joanna Tran
CHCharlie Harris
Charlie Harris
JWJen-Chywan Wang
Jen-Chywan Wang
Glucocorticoids play important roles in the regulation of distinct aspects of adipocyte biology. Excess glucocorticoids in adipocytes are associated with metabolic disorders, including central obesity, insulin resistance and dyslipidemia. To understand the mechanisms underlying the glucocorticoid action in adipocytes, we used chromatin immunoprecipitation sequencing to isolate genome-wide glucocorticoid receptor (GR) binding regions (GBRs) in 3T3-L1 adipocytes. Furthermore, gene expression analyses were used to identify genes that were regulated by glucocorticoids. Overall, 274 glucocorticoid-regulated genes contain or locate nearby GBR. We found that many GBRs were located in or nearby genes involved in triglyceride (TG) synthesis (Scd-1, 2, 3, GPAT3, GPAT4, Agpat2, Lpin1), lipolysis (Lipe, Mgll), lipid transport (Cd36, Lrp-1, Vldlr, Slc27a2) and storage (S3-12). Gene expression analysis showed that except for Scd-3, the other 13 genes were induced in mouse inguinal fat upon 4-day glucocorticoid treatment. Reporter gene assays showed that except Agpat2, the other 12 glucocorticoid-regulated genes contain at least one GBR that can mediate hormone response. In agreement with the fact that glucocorticoids activated genes in both TG biosynthetic and lipolytic pathways, we confirmed that 4-day glucocorticoid treatment increased TG synthesis and lipolysis concomitantly in inguinal fat. Notably, we found that 9 of these 12 genes were induced in transgenic mice that have constant elevated plasma glucocorticoid levels. These results suggested that a similar mechanism was used to regulate TG homeostasis during chronic glucocorticoid treatment. In summary, our studies have identified molecular components in a glucocorticoid-controlled gene network involved in the regulation of TG homeostasis in adipocytes. Understanding the regulation of this gene network should provide important insight for future therapeutic developments for metabolic diseases.